1 Guidance

1 Guidance

1.1

Current evidence on the safety and efficacy of palliative photodynamic therapy (PDT) for advanced oesophageal cancer is of poor quality but appears adequate to support the use of this procedure to relieve symptoms in patients with a poor prognosis. Clinicians wishing to use this procedure should ensure that normal arrangements are in place for consent, audit and clinical governance.

1.2

Palliative PDT for advanced oesophageal cancer should only be performed in specialist centres with regular experience in surgery for oesophageal cancer.